Clinical Trials at Hematology Oncology Associates of Central New York-East Syracuse
As of August 2026, 12 paid clinical trials are recruiting at Hematology Oncology Associates of Central New York-East Syracuse in East Syracuse, New York. Active studies at this site cover conditions such as Alzheimer Disease, Anatomic Stage II Breast Cancer AJCC v8 and Atopic Dermatitis. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
12 clinical trials at Hematology Oncology Associates of Central New York-East Syracuse
·Clear filters·Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Common conditions studied in East Syracuse
- Alzheimer Disease (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Atopic Dermatitis (2 active studies)
- Breast Cancer (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Diabetic Peripheral Neuropathic Pain (2 active studies)
Leading research sponsors in East Syracuse
- Pfizer
- Alliance for Clinical Trials in Oncology
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in East Syracuse?
There are approximately 57 recruiting clinical trials in East Syracuse, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in East Syracuse pay participants?
Most recruiting trials in East Syracuse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in East Syracuse?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in East Syracuse?
The most common conditions under active study in East Syracuse include Alzheimer Disease (2), Anatomic Stage II Breast Cancer AJCC v8 (2), Atopic Dermatitis (2), Breast Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in East Syracuse?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in East Syracuse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in East Syracuse?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in East Syracuse?
Recruiting research sites in East Syracuse include Hematology Oncology Associates of Central New York-East Syracuse, Hematology Oncology Associates of Central New York, Hematology Oncology Associates of Central New York, PC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in East Syracuse right now?
The largest active categories in East Syracuse are Cancer & tumors (31), Diabetes & metabolic (4), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.